Abstract
There is abundant evidence that serotonin (5-hydroxytryptamine, 5-HT) is involved in anxiety in both animals and humans but there is conflicting evidence for the precise role it plays. Acute tryptophan depletion provides a technique for investigating a global reduction in brain 5-HT function and we have investigated its effect on anxiety in drug-free panic disorder patients and normal volunteers. We found little effect on general levels of anxiety but it enhanced the effect of a panic challenge using 5% carbon dioxide (5%CO2) in panic disorder patients. The effect in normal volunteers was less clear with no overall effect following 5%CO2 challenge or the psychological challenge of a simulated public speaking task. These results are discussed in relation to the literature and are broadly supportive of the hypothesis that 5-HT acts to inhibit panic anxiety at the level of the periaqueductal grey but facilitates general and conditioned anxiety at the level of medial temporal lobe structures.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Abbott, F.V., Etienne, P., Franklin, K.B.J., Morgan, M.J., Sewitch, M.J., and Young, S.N., 1992, Acute tryptophan depletion blocks morphine analgesia in the cold-pressor test in humans. Psychopharmacology 108:60–66.
Anderson, I.M., Parry-Billings, M., Newsholme, E.A., Fairburn, C.G., and Cowen, P.J., 1990, Dieting reduces plasma tryptophan and alters brain 5-HT function in women. Psychol. Med. 20:785–791.
Aronson, S.C., Black, J.E., McDougle, C.J., Scanley, B.E., Jatlow, P., Kosten, T.R., Heninger, G.R., and Price, L.H., 1995, Serotonergic mechanisms of cocaine effects in humans. Psychopharmacology 119:179–185.
Audi, E.A., de Aguiar, J.C., and Graeff, F.G., 1988, Mediation by serotonin of the antiaversive effect of zime-lidine and propranolol injected into the dorsal midbrain central grey. Psychopharmacology 2:26–32.
Barr, L.C., Goodman, W.K., McDougle, C.J., Delgado, P.L., Heninger, G.R., Charney, D.S., and Price, L.H., 1994, Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors. Arch. Gen. Psychiatr. 51:309–317.
Barr, L.C., Heninger, G.R., Goodman, W., Charney, D.S., and Price, L.H., 1997, Effects of fluoxetine administration on mood response to tryptophan depletion in healthy subjects. Biol. Psychiatry 41:949–954.
Benkelfat, C., Ellenbogen, M.A., Dean, P., Palmour, R.M., and Young, S.N., 1994, Mood-lowering effect of tryptophan depletion: Enhanced susceptibility in young men at genetic risk for major affective disorders. Arch. Gen. Psychiatr. 51:687–697.
Benkelfat, C., Seletti, B., Palmour, R.M., Hillel, J., Ellenbogen, M., and Young, S.M., 1995, Tryptophan depletion in stable lithium-treated patients with bipolar disorder in remission. Arch. Gen. Psychiatr. 52:154–155.
Bhatti, T., Gillin, J.C., Seifritz, E., Moore, P., Clark, C., Golshan, S., Stahl, S., Rapaport, M., and Kelsoe, J., 1998, Effects of a tryptophan-free amino acid drink challenge on normal human sleep encephalogram and mood. Biol. Psychiatry 43:52–59.
Bond, A.J., Feizollah, S., and Lader, M.H., 1995, The effects of D-fenfluramine on mood and performance, and on neuroendocrine indicators of 5-HT function. Psychopharmacology 9:1–8.
Campbell, D.B., 1991, Dexfenfluramine: an overview of its mechanisms of action. Rev. Contemp. Pharmacol. 2:93–113.
Cappiello, A., Sernyak, M.J., Malison, R.T., McDougle, C.J., Heninger, G.R., and Price, L.H., 1997, Effects of acute tryptophan depletion in lithium-remitted manic patients: a pilot study. Biol. Psychiatry 42:1076–1078.
Carpenter, L.L., Anderson, G.M., Pelton, G.H., Gudin, J.A., Kirwin, P.D.S., Price, L.H., Heninger, G.R., and McDougle, C.J., 1998, Tryptophan depletion during continuous CSF sampling in healthy human subjects. Neuropsychopharmacology 19:26–35.
Cassidy, F., Murry, E., and Carroll, B.J., 1998, Tryptophan depletion in recently remitted manic patients treated with lithium. Biol. Psychiatry 43:230–232.
Charney, D.S., Woods, S.W., Krystal, J.H., Nagy, L.M., and Heninger, G.R., 1991, Hypotheses relating serotonergic dysfunction to the etiology and treatment of panic and generalized anxiety disorders, in: Serotonin in Major Psychiatric Disorders, Volume (E.F. Coccaro and D.L. Murphy, es.), pp. 129–152, American Psychiatric Press Inc, Washington, DC.
Cleare, A.J. and Bond, A.J., 1995, The effect of tryptophan depletion and enhancement on subjective and behavioural aggresssion in normal male subjects. Psychopharmacology 118:72–81.
Coplan, J.D., Gorman, J.M., and Klein, D.F., 1992, Serotonin related functions in panic-anxiety: a critical overview. Neuropsychopharmacology 6:189–200.
Deakin, J.F.W. and Graeff, F.G., 1991, 5HT and mechanisms of defence. J. Psychopharmacol. 5:305–315.
Deakin, J.F.W., Guimaraes, F.S., and Graeff, F.G., 1994, Testing 5HT theories of anxiety in normal volunteers, in: Strategies for Studying Brain Disorders. Volume 1. Depressive, Anxiety and Drug Abuse Disordes, Volume (T. Palomo and T. Archer, eds.), pp. 211–238, Farrand Press, London.
Delgado, P.L., Charney, D.S., Price, L.H., Aghajanian, G.K., Landis, H., and Heninger, G.R., 1990, Serotonin function and the mechanism of antidepressant action: Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch. Gen. Psychiatr. 47:411–418.
Delgado, P.L., Price, L.H., Miller, H.L., Salomon, R.M., Aghajanian, G.K., Heninger, G.R., and Charney, D.S., 1994, Serotonin and the neurobiology of depression: Effects of tryptophan depletion in drug-free depressed patients. Arch. Gen. Psychiatr. 51:865–874.
Den Boer, J.A. and Westenberg, H.G.M., 1990, Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin. J. Psychopharmacol. 102:85–94.
Dillon, D.J., Gorman, J.M., Liebowitz, M.R., Fyer, A.J., and Klein, D.F., 1987, Measurement of lactate-induced panic and anxiety. Psychiatry Res. 20:97–105.
Ellenbogen, M.A., Young, S.N., Dean, P., Palmour, R.M., and Benkelfat, C., 1996, Mood response to acute tryptophan depletion in healthy volunteers: sex differences and temporal stability. Neuropsychopharmacology 15:465–474.
Goddard, A.W., Sholomskas, D.E., Walton, K.E., Augeri, F.M., Charney, D.S., Heninger, G.R., Goodman, W.K., and Price, L.H., 1994, Effects of tryptophan depletion in panic disorder. Biol. Psychiatry 36:775–777.
Goddard, A., Charney, D.S., Germine, M., Woods, S.W., Heninger, G.R., Krystal, J.H., Goodman, W.K., and Price, L.H., 1995, Effects of tryptophan depletion on responses to yohimbine in healthy human subjects. Biol. Psychiatry 38:74–86.
Gray, J.A., 1987, The Psychology of Fear and Stress, Cambridge University Press, Cambridge.
Handley, S.L., 1991, Serotonin in animal models of anxiety: the importance of stimulus and response, in: Serotonin, Sleep and Mental Disorder, (C. Idzikowski and P.J. Cowen, eds.), pp. 89–115, Wrightson Biomedical Publishing Ltd, London.
Hodges, H., Green, S., and Glenn, B., 1987, Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not in discrimination. Psychopharmacology 92:491–504.
Kahn, R.S. and Moore, C., 1993, Serotonin in the pathogenesis of anxiety, in: Biology of Anxiety Disorders, (R. Hoehn-Saric and D.R. McLeod, eds.), pp. 61–102, American Psychiatric Press, Washington DC.
Kent, J.M., Coplan, J.D., Martinez, J., Karmally, W., Papp, L.A., and Gorman, J.M., 1996, Ventilatory effects of tryptophan depletion in panic disorder: a preliminary report. Psychiatry Res. 64:83–90.
Kiser, R.S., Jr. and Lebovitz, R.M., 1975, Monoaminergic mechanisms in aversive brain stimulation. Physiol. Behav. 15:47–53.
Klaassen, T., Klumperbeek, J., Deutz, N.E.P., Van-Praag, H.M., and Griez, E., 1998, Effects of tryptophan depletion on anxiety and on panic provoked by carbon dioxide challenge. Psychiatry Res. 77:167–174.
Koszycki, D., Zacharko, R.M., Le Melledo, J.-M., Young, S.N., and Bradwejn, J., 1996, Effect of acute tryptophan depletion on behavioural cardiovascular, and hormonal sensitivity to cholecystokinin-tetapeptide challenge in healthy volunteers. Biol. Psychiatry 40:648–655.
Lam, R.W., Zis, A.P., Grewal, A., Delgado, P.L., Charney, D.S., and Krystal, J.H., 1996, Effects of rapid tryptophan depletion in patients with seasonal affective disorder in remission after light therapy. Arch. Gen. Psychiatr. 53:41–44.
Le Doux, J.E., 1991, Emotion and the limbic system concept. Conc. Neurosci. 2:169–199.
Le Doux, J.E., Iwata, J., Cicchetti, P., and Reis, D.J., 1988, Different projections of the central amygdaloid nucleus mediate autonomic and behavioural correlates of conditioned fear. Journal of Neuroscience 8:2517–2529.
Leyton, M., Young, S.N., Blier, P, Ellenbogen, M.A., Palmour, R.M., Ghadirian, A.-M., and Benkelfat, C., 1997, The effect of tryptophan depletion on mood in medication-free former patients with major affective disorder. Neuropsychopharmacology 16:294–297.
McDougle, C.J., Naylor, S.T., Cohen, D.J., Aghajanian, G.K., Heninger, G.R., and Price, L.H., 1996, Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch. Gen. Psychiatr. 53:993–1000.
McNair, D.M., Lorr, M., and Droppelman, L.F., 1971, Manual for the Profile of Mood States, Educational and Industrial Testing Service, San Diego, California.
Menkes, D.B., Coates, D.C., and Fawcett, J.P., 1994, Acute tryptophan depletion aggravates premenstrual syndrome. J. Aff. Dis. 32:37–44.
Miller, H., Deakin, J.F.W., and Anderson, I.M., 1995, Acute tryptophan depletion increases panic anxiety in panic disorder patients. J. Psychopharmacol. 9(Suppl.):A18.
Montgomery S.A. and Fineberg N. 1989 Is there a relationship between serotonin receptor subtypes and selectivity of response in specific psyciatric illness-Br. J. Psychiatr. 155Suppl. 863–70
Moore, P., Gillin, C., Bhatti, T., DeModena, A., Seifritz, E., Clark, C., Stahl, S., Rapaport, M., and Kelsoe, J., 1998, Rapid tryptophan depletion, sleep electroencephalogram, and mood in men with remitted depression on serotonin reuptake inhibitors. Arch. Gen. Psychiatr. 55:534–539.
Mortimore, C., Connell, J., and Van, F., 1997, Acute tryptophan depletion in healthy human subjects: effects on two anxiety paradigms. J. Psychopharmacol. 11(Suppl.):A26.
Neumeister, A., Praschak-Rieder, N., Hesselmann, B., Rao, M.-L., Gluck, J., and Kasper, S., 1997, Effects of tryptophan depletion on drug-free patients with seasonal affective disorder during a stable response to bright light therapy. Arch. Gen. Psychiatr. 54:133–138.
Neumeister, A., Praschak-Rieder, N., Hesselmann, B., Vitouch, O., Rauh, M., Barocka, A., Tauscher, J., and Kasper, S., 1998a, Effects of tryptophan depletion in drug free depressed patients who responded to total sleep deprivation. Arch. Gen. Psychiatr. 55:167–172.
Neumeister, A., Turner, E.H., Matthews, J.R., Postolache, T.T., Barnett, R.L., Rauj, M., Vetticad, R.G., Kasper, S., and Rosenthal, N.E., 1998b, Effects of tryptophan depletion vs catecholamine depletion in patients with seasonal affective disorder in remission with light therapy. Arch. Gen. Psychiatr. 55:524–530.
Nishizawa, S., Benkelfat, C., Young, S.N., Leyton, M., Mzengeza, S., de Monyigny, C., Blier, P., and Diksic, 1997, Differences between males and females in rates of serotonin synthesis in human brain. Proc. Nat. Acad.Sci.(USA) 94:5308–5313.
Oldman, A.D., Walsh, A.E.S., Salkovskis, P., Laver, D.A., and Cowen, P.J., 1994, Effect of acute tryptophan depletion on mood and appetite in healthy female volunteers. J. Psychopharmacol. 8:8–13.
Pangalila-Ratu, Langi, E.A. and Jansen, A.A.I., 1988, Ritanserin in the treatment of generalized anxiety disorders: a placebo-controlled trial. Hum. Psychopharmacol. 3:207–212.
Park, S.B., Coull, J.T., McShane, R.H., Young, A.H., Sahakian, B.J., Robbins, T.W., and Cowen, P.J., 1994, Tryptophan depletion in normal volunteers produces selective impairments in learning and memory. Neuropharmacology 33:575–588.
Price, L.H., Malison, R.T., McDougle, C.J., McCance-Katz, E.F., Owen, K.R., and Heninger, G.R., 1997, Neurobiology of tryptophan depletion: effects of m-chlorophenypiperazine (mCPP). Neuropsychopharmacology 17:342–350.
Price, L.H., Malison, R.T., McDougle, C.J., Pelton, G.H., and Heninger, G.R., 1998, The neurobiology of tryptophan depletion in depression: effects of intravenous tryptophan infusion. Biol. Psychiatry 43:339–347.
Rasmusson, A.M., Anderson, G.M., Lynch, K.A., McSwiggan-Hardin, M., Scahill, L.D., Mazure, C.M., Goodman, W.K., Price, L.H., Cohen, D.J., and Leckman, J.F., 1997, A preliminary study of tryptophan depletion on tics, obsessive-compulsive symptoms, and mood in Tourette’s syndrome. Biol Psychiatry 41:117–121.
Reilly, J.G., McTavish, S.F.B., and Young, A.H., 1997, Rapid depletion of plasma tryptophan: a review of studies and experimental methodology. J. Psychopharmacol. 11:381–392.
Sanderson, W.C. and Wetzler, S., 1990, Five percent carbon dioxide challenge: valid analogue and marker of panic disorder? Biol. Psychiatry 27:689–701.
Satel, S.L., Krystal, J.H., Delgado, P.L., Kosten, T.R., and Charney, D.S., 1995, Tryptophan depletion and attenuation of cue-induced craving for cocaine. Am. J. Psychiatr. 152:778–783.
Schutz, M.T.B., de Aguiar, J.C., and Graeff, F.C., 1985, Anti-aversive role of serotonin on the dorsal periaqueductal grey matter. Psychopharmacology 85:340–345.
Shear, M.K., 1990, Psychological perspectives on pharmacological challenge testing. in: Neurobiology of Panic Disorder, (J.C. Ballenger, ed.), pp. 173–186, Wiley-Liss, New York.
Sheehan, D.V., Raj, A.B., Harnett-Sheehan, K., Soto, S., and Knapp, E., 1993, The relative efficacy of high-dose buspirone and alprazolam in the treatment of panic disorder: a double-blind placebo-controlled study. Acta Psychiatr. Scand. 88:1–11.
Smeraldi, E., Diaferia, G., Erzegovesi, S., Lucca, A., Bellodi, L., and Moja, E.A., 1996, Tryptophan depletion in obsessive-compulsive patients. Biol. Psychiatry 40:398–402.
Smith, K.A., Clifford, E.M., Hockney, R.A., Clark, D.M., and Cowen, P.J., 1997a, Effect of tryptophan depletion on mood in male and female volunteers: a pilot study. Hum. Psychopharmacol. 12:111–117.
Smith, K.A., Fairburn, C.G., and Cowen, P.J., 1997b, Relapse of depression after rapid depletion of tryptophan. Lancet 349:915–919.
Smith, S.E., Pihl, R.O., Young, S.N., and Ervin, F.R., 1987, A test of possible cognitive and environmental influences on the mood lowering effect of tryptophan depletion in normal males. Psychopharmacology 91:451–457.
Speilberger, C.D., Gorsuch, R.L., and Lushese, R.E., 1970, Manual for the state-trait anxiety inventory, Consulting Psychologists Press, Palo Alto, CA.
Targum, S.D. and Marshall, L.E., 1989, Fenfluramine provocation of anxiety in patients with panic disorder. Psychiatry Res. 28:295–306.
Weltzin, T.E., Fernstrom, J.D., McConaha, C., and Kaye, W.H., 1994, Acute tryptophan depletion in bulimia: effects on large neutral amino acids. Biol. Psychiatry 35:388–397.
Young, S.N., Smith, S.E., Pihl, R., and Ervin, F.R., 1985, Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology 87:173–177.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Anderson, I.M., Mortimore, C. (1999). 5-Ht and Human Anxiety: Evidence from Studies Using Acute Tryptophan Depletion. In: Huether, G., Kochen, W., Simat, T.J., Steinhart, H. (eds) Tryptophan, Serotonin, and Melatonin. Advances in Experimental Medicine and Biology, vol 467. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4709-9_6
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4709-9_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7133-5
Online ISBN: 978-1-4615-4709-9
eBook Packages: Springer Book Archive